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Abstract
Background: To investigate the controlling efficacy of ondasetron and haloperidol in regard to the
postcardiotomy delirium.
Methods: We included in this prospective, randomized, double-blinded study 80 patients who developed delirium
after heart surgery with the application of heart lung-machine. The patients were divided into two, equally-sized
groups, which on detection of delirium received ondasetron 8 mg iv or haloperidol 5 mg iv respectively. The
statistical analysis compared the baseline and demographic characteristics of the two groups (age, gender,
comorbidities, years of education, type of surgery etc.).
Results: Both ondasetron and haloperidol had very good delirium controlling effects, without statistically
significant differences.
Discussion-Conclusions: Ondasetron and haloperidol are efficient agents as far as the treatment of
postcardiotomy delirium is concerned. As, in addition, ondasetron bares milder side-effects, we believe this could
be the agent of choice in patients developing postcardiotomy delirium in the future.
Background
Neuropsychiatric complications belong to the most com-
mon and feared ones after heart surgery. They include a
variety of nosological entities, such as ischemic/embolic
stroke, transient ischemic attack, postoperative cognitive
decline and postoperative delirium [1-3]; in the broad
sense, ocular neurosensory disorders ranging from blurred
vision to amaurosis fugax also fall to the same category
[4]. The pathophysiological background of these disorders
includes low cerebral perfusion pressure, especially during
extracorporeal circulation, various sorts of embolism
(through clot, atheromatic or gas particles) and the influ-
ence of the anesthetic drugs regimen. Predisposing/preci-
pitating factors regarding the patient’s medical condition
and baseline characteristics include previous stroke, occlu-
sive carotid artery disease, diabetes mellitus, atrial
fibrillation, peripheral occlusive arteriopathy and low edu-
cational niveau [1-3,5]. Procedure-related conditions
enhancing the danger for the development of these com-
plications include urgent surgery, long duration of surgery,
long duration of extracorporeal circulation, long aortic
cross-clamp time and type of surgery (on-pump) [1-3,5,6].
Postoperative delirium can be an extremely unpleasant
situation because of the following characteristics: i) it
occurs at a high frequency, ranging from 8% to 32% of
heart-operated patients [1-3,7,8] ii) it usually appears
during the first hours/days after extubation and totally
disorganizes the patient right when he needs to be
focused on his rehabilitation, iii) it can be accompanied
by serious injuries of the patient (e.g. falling from bed or
violent removal of central venous/arterial lines or epicar-
dial electrodes) iv) it can be the cause of life-threatening
arrhythmias or unexpected elevation of blood pressure v)
there is no special and generally accepted algorithm for
its treatment except for general symptomatic measures
(fixation of the patient) or application of sedative/
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psychotropic drugs with possible subsequent occurrence
of related complications. Herein, we are presenting our
own experience with a prospective, randomized, double
blinded study comparing ondasetron and haloperidol in
regard to their delirium-controlling efficacy after heart
surgery.
Ondasetron
Ondasetron is a serotonin 5HT-3 antagonist, mainly used
as an agent against nausea and vomiting; it is usually
applied to patients after chemo- or radiotherapy or after
surgery [8]. Many authors believe that the drug can be
also indicated in other morbid situations such as schizo-
phrenia, Parkinson’s disease and alcohol addiction with
beneficial psychotropic effects for the related patients. It
is generally considered as a safe medicine with the most
known side-effects being constipation, dizziness and light
headache. Ondasetron is metabolized hepatically,
excreted renally and has a half-life of 5.7 h. Its chemical
structure is shown on Figure 1.
In 2000 [9,10], Bayindir et al., published the results
of an interesting study which reported a good
controlling effect of intravenously administered onda-
setron (8 mg) in patients with postcardiotomy delir-
ium. These results have never been confirmed by a
larger study; furthermore, no direct comparison of
ondasetron with other pharmaceutical agents has ever
been performed by the aforementioned or another
research.
Haloperidol
Haloperidol is a potent neuroleptic and psychotropic agent
belonging to the group of butyrophenones. It mediates its
action through blockade of dopaminergic receptors in the
mesocortex and limbic system of the brain. Secondarily, it
also has antimuscarinic and anticholinergic properties.
Haloperidol has a significant efficacy against delirium and
hallucinations, as well as anti-nausea and antivomiting
properties. It is most commonly used in schizophrenia,
acute psychotic states and delirium. Its most known side-
efffects are the extrapyramidal ones (akathisia, tardive dys-
kinesia, muscle stiffness). Haloperidol is hepatically meta-
bolised, biliary-renally excreted and has a half-life of 12-36





Figure 1 Chemical structure of ondasetron.
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Methods
After the ethics committee approval and the patients’/
relatives’ informed consent we recruited for the study 80
consecutive patients who developed postoperative delir-
ium after on-pump heart surgery (coronary artery
bypass graft surgery, aortic valve replacement surgery,
mitral valve surgery or combined procedures). The
patients were gathered during a 3-year period (2008-
2010) out of a total of 600 patients operated during the
same period in our department. Exclusion criterion for
the study was the history of severe psychiatric disease
(schizophrenia, bipolar disorders). For the detection and
evaluation of postoperative delirium we applied a practi-
cal scale, similar to that used by Bayindir et al. [8]. This
4-point scale was rated as follows: 0-normal, 1-patient
with restlessness and mild confusion but cooperative, 2-
patient disorientated but cooperative, memory gaps, 3-
patient disorientated and uncooperative with augmented
mobility that could put him to danger, 4-patient totally
disorientated, violent and aggressive, presence of halluci-
nations. We divided our sample patients into two
groups: i) the ondasetron group, whose members were
given 8 mg ondasetron iv on detection of delirium, ii)
the haloperidol group, whose patients were given 5 mg
haloperidol iv. The two substances were administered at
a random, alternate (one but one) order. All patients
were evaluated before and 10 min after the injection
with the aforementioned scale. The idea for a third, pla-
cebo control group was abolished as we considered dan-
gerous and unethical to leave these patients totally
untreated for their delirious condition.
Statistical analysis
For the statistical analysis, the c2 criterion was used for
categorical parameters and the t-student unpaired for
the continuous ones. The t-student (paired) criterion
was applied to check for test scoring differences prior
and after the drugs administration within each group.
The ANOVA continuous measurements and the com-
parison of percentages were used to check for differ-
ences in the test scoring improvement between the two
groups. The Kolmogorov-Smirnov test was used to
check for normal distribution of the values. The level of
statistical significance was set at a value for p < 0.05.
Results
There were no significant differences regarding the base-
line characteristics between the two groups. We noted a
statistically significant improvement in the test score rat-
ing after the administration of both ondasetron (from 3.1
to 1.2, percentage improvement 61.29%, p < 0.01) and
haloperidol (from 3.1 to 1.3, ± percentage improvement
58.064%, p < 0.01). No statistically significant differences
were found as far as the post-application improvement
between the two groups is concerned. 7 patients in the
ondasetron group and 6 in the haloperidol group
remained delirious after the pharmaceutical application,
had to be fixated and returned to calmness after falling
asleep in a period ranging from 2-5 hour. The aforemen-
tioned data are depicted in detail in Tables 1 and 2.
Discussion
Postoperative delirium remains a major problem for
patients undergoing any kind of heart surgery. Besides
their heart condition, these patients are usually of an
increased age and carry multiple morbid conditions,
such as diabetes mellitus, arterial hypertension, previous
stroke, occlusive carotid artery disease etc. The occur-
ence of delirium hinders their normal course of recovery
and rehabilitation, endangers their life through various
injuries, prolongs their ICU and hospital stay, the num-
ber of rehospitalizations, and finally, the total hospitali-
zation expenditure [11]. For these reasons we planned
and performed this study in an effort to establish a safe
and standard pharmacological approach for the treat-
ment of postoperative delirium.
 
Figure 2 Chemical structure of haloperidol.
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We included in our comparative analysis two well-
known agents: ondasetron, with good anti-nausea and
antivomiting properties and haloperidol, a widely used
neuroleptic and psychotropic agent recruited against
acute psychotic conditions and hallucinations. Our study
concluded to an excellent and equal delirium-controlling
effect of the two drugs. Although this has been known
for haloperidol, it consists practically new knowledge for
ondasetron, as only one study (by Bayindir et al.) in the
past has reached the same result; this study had the dis-
advantage of being based on a small sample of patients
and of missing comparative information with another,
already used delirium-controlling agent (as for example
in our study haloperidol). If we expand our comparison
between ondasetron and haloperidol to other para-
meters, we can say that they both are low-cost agents,
but ondasetron is safer and with milder side-effects. For
these reasons we believe that ondasetron, although lack-
ing an official indication, is the agent of choice for post-
cardiotomy delirium, as it is efficacious, inexpensive and
safe. Further and larger studies are needed to support
our findings, but also to expand ondasetron’s indications
not only to postcardiotomy delirium, but to other kinds
of delirium as well.
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